Categories

Volume 5 Issue 12 (December, 2017)

Original Articles

Clinico- pathological Analysis of 68 cases of Ameloblastoma- A Retrospective Study
Namrata Punit Awasthi, Poonam Singh

Background: The ameloblastoma is a benign odontogenic tumor solely derived from an odontogenic epithelial origin, and it alone accounts for around 23% of odontogenic tumors. The present study was conducted to correlate the recurrence rates of benign ameloblastoma to the inherent nature of different clinic-pathological subtypes. Materials & Methods: This retrospective study included 68 treated cases of ameloblastoma. General information such as name, age, gender, anatomic location and histologic subtype were evaluated. Benign ameloblastoma were divided into: unicystic ameloblastoma (UA), solid/multicystic ameloblastoma (SMA), and desmoplastic ameloblastoma based on WHO (2005) classification. This was based on histopathological evaluation of tissue sections stained with hematoxylin and eosin stains. The solid variant was further subdivided into the follicular and plexiform variants. Results: Out of 68 cases of ameloblastoma, males were involved in 45 cases and females in 23 cases. The difference was significant (P< 0.05). Most commonly seen variety was follicular (24) followed by unicystic (20), plexiform (13) and desmoplastic (11). Most cases were involving right posterior mandible (30) followed by left posterior mandible (19), right & left posterior mandible together (7), anterior mandible (5), posterior maxilla (4) and anterior maxilla (3). The difference was significant (P< 0.05). Most common variant seen was follicular which showed recurrence. Most common site was left posterior mandible. Male predominated in recurrence cases.
Conclusion: Follicular variety was commonly showed recurrence and posterior mandible predominance was seen. Male predominance was observed in this study.
Key words: Ameloblastoma, Follicular, Plexiform.

 
Html View | Download PDF | Current Issue


 
This work is licensed under a Creative Commons Attribution 3.0 License.  
?>